Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency Applying Intravenous Immunoglobulin During Intravenous Access: A Crossover Randomized Controlled Trial

NCT07004803 is registered in ClinicalTrials.gov with Dr. Hatice Dönmez as lead sponsor.

NCT NCT07004803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency Applying Intravenous Immunoglobulin During Intravenous Access: A Crossover Randomized Controlled Trial
Lead sponsor
Dr. Hatice Dönmez
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2024
Completion date
June 15, 2025
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency diseases (pid)